These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 14414644)

  • 1. [Study of poliomyelitis antibodies in Lorraine before, during and after vaccination with the Lepine vaccine in a group of subjects observed systematically].
    de LAVERGNE ; GERBAUT P; LORRAIN J; POLJE F; GILGENKRANTZ ; LE MOYNE MT; MATHIEU J
    Ann Inst Pasteur (Paris); 1959 Dec; 97():848-54. PubMed ID: 14414644
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-poliomyelitis vaccination with inactivated virus (Lepine vaccine). Effect of the booster injection on immunization].
    MARTIN R; ROGER F; DAMAS JP; ROGER A; JUILLARD P
    Bull Acad Natl Med; 1961 Nov 21-28; 145():664-73. PubMed ID: 14470436
    [No Abstract]   [Full Text] [Related]  

  • 3. [2 1/2 Years of antipoliomyelitis vaccination (Lepine vaccine) at the Institut Pasteur hospital. Immunological results. Significance of the booster injection].
    MARTIN R; ROGER F; DAMAS JP; ROGER A
    Ann Inst Pasteur (Paris); 1959 Dec; 97():757-79. PubMed ID: 14421731
    [No Abstract]   [Full Text] [Related]  

  • 4. [The formation of neutralizing antibodies in humans after poliomyelitis immunization with the Behring vaccine].
    KELLER W; SAUTHOFF R
    Dtsch Med Wochenschr; 1955 Sep; 80(37):1329-31. PubMed ID: 13261706
    [No Abstract]   [Full Text] [Related]  

  • 5. [Examinations on poliomyelitis antibodies in the population and the practical significance of antibody determination in poliomyelitis vaccination].
    KELLER W
    Monatsschr Kinderheilkd (1902); 1956 Mar; 104(3):135-6. PubMed ID: 13321825
    [No Abstract]   [Full Text] [Related]  

  • 6. [Poliomyelitis antibody development in adults after vaccination with Lederle triple vaccine of Sabin strains].
    GSELL O; WIESMANN E
    Schweiz Med Wochenschr; 1962 Apr; 92():475-6. PubMed ID: 13902511
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies in human subjects on active immunization against poliomyelitis. II. A practical means for inducing and maintaining antibody formation.
    SALK JE; BAZELEY PL; BENNETT BL; KRECH U; LEWIS LJ; WARD EN; YOUNGNER JS
    Am J Public Health Nations Health; 1954 Aug; 44(8):994-1009. PubMed ID: 13180761
    [No Abstract]   [Full Text] [Related]  

  • 8. [Some questions of the theory of live vaccine and vaccination against poliomyelitis with Sabin vaccine].
    GINSBURG NN
    Vopr Virusol; 1959; 4():620-4. PubMed ID: 13850246
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of antibodies neutralizing the 3 types of poliovirus in children of the second and third stages of childhood given antipoliomyelitis vaccination with the Salk type of vaccine].
    SEGAGNI E; ANSALDI N; NIGRO N
    Minerva Pediatr; 1960 Apr; 12():518-22. PubMed ID: 14444520
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccination with Koprowski's live attenuated polio vaccine in the area of Gdansk and Olsztyn provinces. III. Investigations of the rise of antibodies in the course of vaccination with Koprowski's live, attenuated polio vaccine.
    GEORGIADES J
    Biul Inst Med Morsk Gdansk; 1961; 12():37-44. PubMed ID: 13897795
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccination against poliomyelitis with live virus vaccines. I. A trial of TN type II vaccine.
    CONNOLLY JH; DANE DS; DICK GW; FISHER OD; MCKEOWN F
    Br Med J; 1957 Jan; 1(5010):59-65. PubMed ID: 13383193
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vaccination in Poland with a live attenuated vaccine against poliomyelitis].
    PRZESMYCKI F; DOBROWOLSKA H; OLAKOWSKI T; STANCZYK R; NARUSZEWICZ D
    Med Dosw Mikrobiol; 1960; 12():1-14. PubMed ID: 14435187
    [No Abstract]   [Full Text] [Related]  

  • 13. POLIOMYELITIS vaccine.
    J Am Med Assoc; 1956 Sep; 162(2):115. PubMed ID: 13357300
    [No Abstract]   [Full Text] [Related]  

  • 14. [Poliomyelitis vaccination--live vaccine?].
    LERCHE C
    Tidsskr Nor Laegeforen; 1961 Jun; 81():725-7. PubMed ID: 13761043
    [No Abstract]   [Full Text] [Related]  

  • 15. The relationship between specific skin reaction and neutralizing antibody titers in the young infant following immunization with poliomyelitis (Salk-type) vaccine.
    MORRONE G; NUNZIATA B
    Ann Paediatr; 1961; 196():389-98. PubMed ID: 13772899
    [No Abstract]   [Full Text] [Related]  

  • 16. [Problem of state testing of poliomyelitis vaccine].
    PRIGGE R; GUNTHER O; BONIN O; EISSNER G
    Dtsch Med Wochenschr; 1956 Mar; 81(11):377-9; concl. PubMed ID: 13317615
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vaccination by quadruple vaccine (diphtheria, whooping cough, tetanus and poliomyelitis)].
    BUTLER N
    Rev Immunol Ther Antimicrob; 1960; 24():167-72. PubMed ID: 13806505
    [No Abstract]   [Full Text] [Related]  

  • 18. [Manufacture and control of poliomyelitis vaccine].
    DE SOMER P
    Brux Med; 1956 May; 36(20):1018-27. PubMed ID: 13316254
    [No Abstract]   [Full Text] [Related]  

  • 19. [The German poliomyelitis vaccine].
    HUNERBEIN J
    Dtsch Med J; 1956 Jun; 7(11-12):395-401. PubMed ID: 13344225
    [No Abstract]   [Full Text] [Related]  

  • 20. PRACTICAL experience with poliomyelitis vaccine.
    Am J Public Health Nations Health; 1956 May; 46(5):547-62. PubMed ID: 13313834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.